Literature DB >> 17710161

c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells.

Amanda Guffei1, Zelda Lichtensztejn, Amanda Gonçalves Dos Santos Silva, Sherif F Louis, Andrea Caporali, Sabine Mai.   

Abstract

Robertsonian (Rb) translocation chromosomes occur in human and murine cancers and involve the aberrant joining of two acrocentric chromosomes in humans and two telocentric chromosomes in mice. Mechanisms leading to their generation remain elusive, but models for their formation have been proposed. They include breakage of centromeric sequences and their subsequent fusions, centric misdivision, misparing between highly repetitive sequences of p-tel or p-arm repeats, and recombinational joining of centromeres and/or centromeric fusions. Here, we have investigated the role of the oncoprotein c-Myc in the formation of Rb chromosomes in mouse cells harboring exclusively telocentric chromosomes. In mouse plasmacytoma cells with constitutive c-Myc deregulation and in immortalized mouse lymphocytes with conditional c-Myc expression, we show that positional remodeling of centromeres in interphase nuclei coincides with the formation of Rb chromosomes. Furthermore, we demonstrate that c-Myc deregulation in a myc box II-dependent manner is sufficient to induce Rb translocation chromosomes. Because telomeric signals are present at all joined centromeres of Rb chromosomes, we conclude that c-Myc mediates Rb chromosome formation in mouse cells by telomere fusions at centromeric termini of telocentric chromosomes. Our findings are relevant to the understanding of nuclear chromosome remodeling during the initiation of genomic instability and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17710161      PMCID: PMC1941693          DOI: 10.1593/neo.07355

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  54 in total

1.  Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.

Authors:  Jane Bayani; Maria Zielenska; Ajay Pandita; Khaldoun Al-Romaih; Jana Karaskova; Karen Harrison; Julia A Bridge; Poul Sorensen; Paul Thorner; Jeremy A Squire
Journal:  Genes Chromosomes Cancer       Date:  2003-01       Impact factor: 5.006

2.  Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression.

Authors:  Asa Karlsson; Debabrita Deb-Basu; Athena Cherry; Stephanie Turner; James Ford; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

3.  Why is the house mouse karyotype so variable?

Authors:  M W Nachman; J B Searle
Journal:  Trends Ecol Evol       Date:  1995-10       Impact factor: 17.712

Review 4.  Conditional transgenic models define how MYC initiates and maintains tumorigenesis.

Authors:  Constadina Arvanitis; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2006-07-21       Impact factor: 15.707

5.  Telomeric aggregates and end-to-end chromosomal fusions require myc box II.

Authors:  A Caporali; L Wark; B J Vermolen; Y Garini; S Mai
Journal:  Oncogene       Date:  2006-09-04       Impact factor: 9.867

Review 6.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

7.  Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.

Authors:  Santiago Silva; Francis Wiener; George Klein; Siegfried Janz
Journal:  Genes Chromosomes Cancer       Date:  2005-04       Impact factor: 5.006

8.  A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity.

Authors:  Kevin M Haigis; William F Dove
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

Review 9.  Acute myelogeneous leukemia (M5a) that demonstrated chromosomal abnormality of robertsonian 13;21 translocation at onset.

Authors:  Takayoshi Shimokawa; Mayuko Sakai; Yumi Kojima; Hideo Takeyama
Journal:  Intern Med       Date:  2004-06       Impact factor: 1.271

10.  c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis.

Authors:  Thierry Fest; Virginie Mougey; Véronique Dalstein; Marlon Hagerty; Danielle Milette; Santiago Silva; Sabine Mai
Journal:  Oncogene       Date:  2002-05-02       Impact factor: 9.867

View more
  15 in total

1.  Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines.

Authors:  Qian Chen; Xiaoyun Shi; Cornelia Rudolph; Yong Yu; Ding Zhang; Xiaoyu Zhao; Sabine Mai; Gang Wang; Brigitte Schlegelberger; Qinghua Shi
Journal:  Chromosome Res       Date:  2011-10-19       Impact factor: 5.239

2.  Expression of cancerous inhibitor of protein phosphatase 2A in human triple negative breast cancer correlates with tumor survival, invasion and autophagy.

Authors:  Shan Li; Ting-Ting Feng; Yang Guo; Xianjun Yu; Qiuyue Huang; Liang Zhang; Wei Tang; Ying Liu
Journal:  Oncol Lett       Date:  2016-11-09       Impact factor: 2.967

3.  Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles.

Authors:  Amanda Guffei; Rahul Sarkar; Ludger Klewes; Christiaan Righolt; Hans Knecht; Sabine Mai
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

4.  Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients.

Authors:  Macoura Gadji; David Fortin; Ana-Maria Tsanaclis; Yuval Garini; Nir Katzir; Yifat Wienburg; Ju Yan; Ludger Klewes; Thomas Klonisch; Régen Drouin; Sabine Mai
Journal:  Neoplasia       Date:  2010-02       Impact factor: 5.715

5.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

6.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

7.  Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.

Authors:  Drazen B Zimonjic; Veronika Ullmannova-Benson; Valentina M Factor; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Cancer Genet Cytogenet       Date:  2009-05

8.  Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma.

Authors:  Amanda Gonçalves Dos Santos Silva; Herbert Alexander Graves; Amanda Guffei; Tatiana Iervolino Ricca; Renato Arruda Mortara; Miriam Galvonas Jasiulionis; Sabine Mai
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

9.  c-Myc suppression of DNA double-strand break repair.

Authors:  Zhaozhong Li; Taofeek K Owonikoko; Shi-Yong Sun; Suresh S Ramalingam; Paul W Doetsch; Zhi-Qiang Xiao; Fadlo R Khuri; Walter J Curran; Xingming Deng
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

Review 10.  c-MYC-induced genomic instability.

Authors:  Alexandra Kuzyk; Sabine Mai
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.